NEWS & MEDIA
What’s new at Fos Biomedical? Here we will share news about our products, events we will be attending, articles and publications of interest relating to the industry.
Viral Response Pilot Study Underway
An approved pilot study is underway that explores the impact of wearing two Fos Biomedical Viral Response devices in combination with orally administered Copper Glycinate (2mg BID) on reducing infectious markers of the blood and antibody markers for COVID-19. In...
Fos Biomedical announce the launch of the Purali Therapeutics website
We are delighted to announce that our new brand Purali Therapeutics website is now live. Visit www.puralitherapeutics.com for more information. Purali Therapeutics is a natural pain management product to help those suffering with osteoarthritis pain. ...
Chronic Pain Coping Inventory
Further Validation of the Chronic Pain Coping Inventory The Chronic Pain Coping Inventory (CPCI), developed to assess coping strategies targeted for change in multidisciplinary pain treatment, is a 64-item instrument that contains 8 subscales: Guarding, Resting,...
NASA Light Emitting Diode Medical Applications From Deep Space to Deep Sea
Abstract. This work is supported and managed through the NASA Marshall Space Flight Center - SBIR Program. LED-technology developed for NASA plant growth experiments in space shows promise for delivering light deep into tissues of the body to promote wound healing and...
Shining light on the head: Photobiomodulation for brain disorders
Michael R. Hamblin, Ph.D. is a Principal Investigator at Wellman Center for Photomedicine, Massachusetts General Hospital, and an Associate Professor Harvard Medical School. We have followed his work for a number of years as he has interests in photodynamic therapy...